DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Soria F, Beleni AI, D’Andrea D. et al.
Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer.
World J Urol 2018;
36: 1703-1709
DOI: 10.1007/s00345-018-2264-0. (PMID: 29549485)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.